Journal of Gastric Cancer

  • 제20권1호
  • /
  • Pages.19-28
  • /
  • 2020
  • /
  • 2093-582X(pISSN)
  • /
  • 2093-5641(eISSN)
대한위암학회 (The Korean Gastric Cancer Association)
권호 표지
DOI QR코드

DOI QR Code

Advantages of Splenic Hilar Lymph Node Dissection in Proximal Gastric Cancer Surgery

  • Guner, Ali (Department of General Surgery, Karadeniz Technical University College of Medicine) ;
  • Hyung, Woo Jin (Department of Surgery, Yonsei University College of Medicine)
  • 투고 : 2019.12.25
  • 심사 : 2020.03.06
  • 발행 : 2020.03.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Gastrectomy with lymph node dissection remains the gold standard for curative treatment of gastric cancer. Dissection of splenic hilar lymph nodes has been included as a part of D2 lymph node dissection for proximal gastric cancer. Previously, pancreatico-splenectomy has been performed for dissecting splenic hilar lymph nodes, followed by pancreas-preserving splenectomy and spleen-preserving lymphadenectomy. However, the necessity of routine splenectomy or splenic hilar lymph node dissection has been under debate due to the increased morbidity caused by splenectomy and the poor prognostic feature of splenic hilar lymph node metastasis. In contrast, the relatively high incidence of splenic hilar lymph node metastasis, survival advantage, and therapeutic value of splenic hilar lymph node dissection in some patient subgroups, as well as the effective use of novel technologies, still supports the necessity and applicability of splenic hilar lymph node dissection. In this review, we aimed to evaluate the need for splenic hilar lymph node dissection and suggest the subgroup of patients with favorable outcomes.

키워드

참고문헌

  1. Takahashi T, Sawai K, Hagiwara A, Takahashi S, Seiki K, Tokuda H. Type-oriented therapy for gastric cancer effective for lymph node metastasis: management of lymph node metastasis using activated carbon particles adsorbing an anticancer agent. Semin Surg Oncol 1991;7:378-383. https://doi.org/10.1002/ssu.2980070610
  2. Coller FA, Kay EB, McIntyre RS. Regional lymphatic metastases of carcinoma of the stomach. Arch Surg 1941;43:748-761. https://doi.org/10.1001/archsurg.1941.01210170015002
  3. Pissas A, Sarrazin R, Dyon JF, Bouchet Y. The lymphatic vessels of the stomach in man. Folia Morphol (Praha) 1982;30:363-365.
  4. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-425. https://doi.org/10.1007/BF01655804
  5. Son T, Hyung WJ, Kim JW, Kim HI, An JY, Cheong JH, et al. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis. Ann Surg Oncol 2014;21:899-907. https://doi.org/10.1245/s10434-013-3403-x
  6. Choi YY, An JY, Guner A, Kang DR, Cho I, Kwon IG, et al. Skip lymph node metastasis in gastric cancer: is it skipping or skipped? Gastric Cancer 2016;19:206-215. https://doi.org/10.1007/s10120-015-0472-5
  7. Sasada S, Ninomiya M, Nishizaki M, Harano M, Ojima Y, Matsukawa H, et al. Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer. Anticancer Res 2009;29:3347-3351.
  8. Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 1981;11:127-139. https://doi.org/10.1007/BF02468883
  9. Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 1989;210:596-602. https://doi.org/10.1097/00000658-198911000-00005
  10. Okajima K, Isozaki H. Splenectomy for treatment of gastric cancer: Japanese experience. World J Surg 1995;19:537-540. https://doi.org/10.1007/BF00294715
  11. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English edition -. Gastric Cancer 1998;1:10-24. https://doi.org/10.1007/PL00011681
  12. Monig SP, Collet PH, Baldus SE, Schmackpfeffer K, Schroder W, Thiele J, et al. Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol 2001;76:89-92. https://doi.org/10.1002/1096-9098(200102)76:2<89::AID-JSO1016>3.0.CO;2-I
  13. Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Hutawatari N, et al. Clinical significance of total gastrectomy for proximal gastric cancer. Anticancer Res 2008;28:2875-2883.
  14. Shin SH, Jung H, Choi SH, An JY, Choi MG, Noh JH, et al. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer. Ann Surg Oncol 2009;16:1304-1309. https://doi.org/10.1245/s10434-009-0389-5
  15. Aoyagi K, Kouhuji K, Miyagi M, Imaizumi T, Kizaki J, Shirouzu K. Prognosis of metastatic splenic hilum lymph node in patients with gastric cancer after total gastrectomy and splenectomy. World J Hepatol 2010;2:81-86. https://doi.org/10.4254/wjh.v2.i2.81
  16. Kosuga T, Ichikawa D, Okamoto K, Komatsu S, Shiozaki A, Fujiwara H, et al. Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients. Gastric Cancer 2011;14:172-177. https://doi.org/10.1007/s10120-011-0028-2
  17. Zhu GL, Sun Z, Wang ZN, Xu YY, Huang BJ, Xu Y, et al. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach. J Surg Oncol 2012;105:786-792. https://doi.org/10.1002/jso.22149
  18. Chen XL, Yang K, Zhang WH, Chen XZ, Zhang B, Chen ZX, et al. Metastasis, risk factors and prognostic significance of splenic hilar lymph nodes in gastric adenocarcinoma. PLoS One 2014;9:e99650. https://doi.org/10.1371/journal.pone.0099650
  19. Yang K, Zhang WH, Chen XZ, Chen XL, Zhang B, Chen ZX, et al. Survival benefit and safety of no. 10 lymphadenectomy for gastric cancer patients with total gastrectomy. Medicine (Baltimore) 2014;93:e158. https://doi.org/10.1097/md.0000000000000158
  20. Sun Z, Wang Q, Yu X, Ou C, Yao L, Liu K, et al. Risk factors associated with splenic hilar lymph node metastasis in patients with advanced gastric cancer in northwest China. Int J Clin Exp Med 2015;8:21358-21364.
  21. Hong ZL, Chen QY, Zheng CH, Li P, Xie JW, Wang JB, et al. A preoperative scoring system to predict the risk of No.10 lymph node metastasis for advanced upper gastric cancer: a large case report based on a single-center study. Oncotarget 2017;8:80050-80060. https://doi.org/10.18632/oncotarget.17273
  22. Watanabe M, Kinoshita T, Enomoto N, Shibasaki H, Nishida T. Clinical significance of splenic hilar dissection with splenectomy in advanced proximal gastric cancer: an analysis at a single institution in Japan. World J Surg 2016;40:1165-1171. https://doi.org/10.1007/s00268-015-3362-4
  23. Son T, Kwon IG, Lee JH, Choi YY, Kim HI, Cheong JH, et al. Impact of splenic hilar lymph node metastasis on prognosis in patients with advanced gastric cancer. Oncotarget 2017;8:84515-84528. https://doi.org/10.18632/oncotarget.18762
  24. Maezawa Y, Aoyama T, Yamada T, Kano K, Hayashi T, Sato T, et al. Priority of lymph node dissection for proximal gastric cancer invading the greater curvature. Gastric Cancer 2018;21:569-572. https://doi.org/10.1007/s10120-017-0775-9
  25. Jeong O, Jung MR, Ryu SY. Clinicopathological features and prognostic impact of splenic hilar lymph node metastasis in proximal gastric carcinoma. Eur J Surg Oncol 2019;45:432-438. https://doi.org/10.1016/j.ejso.2018.10.531
  26. Yura M, Yoshikawa T, Otsuki S, Yamagata Y, Morita S, Katai H, et al. The therapeutic survival benefit of splenic hilar nodal dissection for advanced proximal gastric cancer invading the greater curvature. Ann Surg Oncol 2019;26:829-835. https://doi.org/10.1245/s10434-018-07122-9
  27. Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995;82:346-351. https://doi.org/10.1002/bjs.1800820321
  28. Nashimoto A, Yabusaki H, Matsuki A. The significance of splenectomy for advanced proximal gastric cancer. Int J Surg Oncol 2012;2012:301530. https://doi.org/10.1155/2012/301530
  29. Yura M, Yoshikawa T. ASO author reflections: splenic hilar nodal dissection for proximal advanced gastric cancer. Ann Surg Oncol 2019;26:588-589. https://doi.org/10.1245/s10434-019-07394-9
  30. Csendes A, Burdiles P, Rojas J, Braghetto I, Diaz JC, Maluenda F. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 2002;131:401-407. https://doi.org/10.1067/msy.2002.121891
  31. Sano T, Sasako M, Mizusawa J, Yamamoto S, Katai H, Yoshikawa T, et al. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma. Ann Surg 2017;265:277-283. https://doi.org/10.1097/SLA.0000000000001814
  32. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008;359:453-462. https://doi.org/10.1056/NEJMoa0707035
  33. Kinoshita T. Splenic hilar dissection in the treatment of proximal advanced gastric cancer: what is an adequate strategy? Transl Gastroenterol Hepatol 2016;1:72. https://doi.org/10.21037/tgh.2016.09.05
  34. Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg 2006;93:559-563. https://doi.org/10.1002/bjs.5353
  35. Hyung WJ, Lim JS, Song J, Choi SH, Noh SH. Laparoscopic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. J Am Coll Surg 2008;207:e6-e11.
  36. Huang CM, Chen QY, Lin JX, Zheng CH, Li P, Xie JW, et al. Laparoscopic spleen-preserving splenic hilar lymphadenectomy performed by following the perigastric fascias and the intrafascial space for advanced upper-third gastric cancer. PLoS One 2014;9:e90345. https://doi.org/10.1371/journal.pone.0090345
  37. Ji X, Fu T, Bu ZD, Zhang J, Wu XJ, Zong XL, et al. Comparison of different methods of splenic hilar lymph node dissection for advanced upper- and/or middle-third gastric cancer. BMC Cancer 2016;16:765. https://doi.org/10.1186/s12885-016-2814-z
  38. Huang CM, Huang ZN, Zheng CH, Li P, Xie JW, Wang JB, et al. Huang's three-step maneuver shortens the learning curve of laparoscopic spleen-preserving splenic hilar lymphadenectomy. Surg Oncol 2017;26:389-394. https://doi.org/10.1016/j.suronc.2017.07.010
  39. Guo X, Peng Z, Lv X, Cui J, Zhang K, Li J, et al. Randomized controlled trial comparing short-term outcomes of laparoscopic and open spleen-preserving splenic hilar lymphadenectomy for advanced proximal gastric cancer: an interim report. J Surg Oncol 2018;118:1264-1270. https://doi.org/10.1002/jso.25262
  40. Yang K, Cho M, Roh CK, Seo WJ, Choi S, Son T, et al. Robotic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. Surg Endosc 2019;33:2357-2363. https://doi.org/10.1007/s00464-019-06772-4
  41. Son T, Lee JH, Kim YM, Kim HI, Noh SH, Hyung WJ. Robotic spleen-preserving total gastrectomy for gastric cancer: comparison with conventional laparoscopic procedure. Surg Endosc 2014;28:2606-2615. https://doi.org/10.1007/s00464-014-3511-0
  42. Wang JB, Huang CM, Zheng CH, Li P, Xie JW, Lin JX, et al. Role of 3DCT in laparoscopic total gastrectomy with spleen-preserving splenic lymph node dissection. World J Gastroenterol 2014;20:4797-4805. https://doi.org/10.3748/wjg.v20.i16.4797
  43. Kinoshita T, Shibasaki H, Enomoto N, Sahara Y, Sunagawa H, Nishida T. Laparoscopic splenic hilar lymph node dissection for proximal gastric cancer using integrated three-dimensional anatomic simulation software. Surg Endosc 2016;30:2613-2619. https://doi.org/10.1007/s00464-015-4511-4
  44. Kwon IG, Son T, Kim HI, Hyung WJ. Fluorescent lymphography-guided lymphadenectomy during robotic radical gastrectomy for gastric cancer. JAMA Surg 2019;154:150-158. https://doi.org/10.1001/jamasurg.2018.4267
  45. Kim YM, Baek SE, Lim JS, Hyung WJ. Clinical application of image-enhanced minimally invasive robotic surgery for gastric cancer: a prospective observational study. J Gastrointest Surg 2013;17:304-312. https://doi.org/10.1007/s11605-012-2094-0

피인용 문헌

  1. Is Splenic Hilar Lymph Node Dissection Without Splenectomy Essential for Proximal Advanced Gastric Cancer? vol.28, pp.13, 2020, https://doi.org/10.1245/s10434-021-10354-x